Literature DB >> 19614941

Epidemiology of low bone mineral density and fractures in children with severe cerebral palsy: a systematic review.

Sandra Mergler1, Heleen M Evenhuis, Annemieke M Boot, Stella A De Man, Karen G C B Bindels-De Heus, Wim A R Huijbers, Corine Penning.   

Abstract

AIM: Children with severe cerebral palsy (CP) are at risk for developing low bone mineral density (BMD) and low-impact fractures. The aim of this study was to provide a systematic literature review of the epidemiology of fractures and low BMD in children with severe CP, with an emphasis on risk factors. Gross Motor Function Classification System (GMFCS) levels IV and V were criteria for severe cerebral palsy.
METHOD: The literature (PubMed) was searched and eligible studies were given a level of evidence score using the Scottish Intercollegiate Guidelines Network criteria.
RESULTS: Seven studies were found concerning epidemiology of fractures, 11 studies described epidemiology of low BMD, and 14 studies concerned risk factors. The methodological quality of most of these studies was poor. Five studies were considered well-conducted with low risk of confounding and bias. In these studies, the incidence of fractures in children with moderate to severe CP approached 4% per year, whereas the prevalence of low BMD in the femur was 77%. Limited ambulation, feeding difficulties, previous fractures, anticonvulsant use, and lower body fat mass were associated with low BMD z-scores.
INTERPRETATION: There is only a limited amount of high-quality evidence on low BMD and fractures in children with severe CP.

Entities:  

Mesh:

Year:  2009        PMID: 19614941     DOI: 10.1111/j.1469-8749.2009.03384.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  17 in total

Review 1.  Zoledronic acid in pediatric metabolic bone disorders.

Authors:  Sasigarn A Bowden; John D Mahan
Journal:  Transl Pediatr       Date:  2017-10

Review 2.  Low Energy Availability, Menstrual Dysfunction, and Low Bone Mineral Density in Individuals with a Disability: Implications for the Para Athlete Population.

Authors:  Cheri A Blauwet; Emily M Brook; Adam S Tenforde; Elizabeth Broad; Caroline H Hu; Eliza Abdu-Glass; Elizabeth G Matzkin
Journal:  Sports Med       Date:  2017-09       Impact factor: 11.136

3.  Bone mineral density and vitamin D status in ambulatory and non-ambulatory children with cerebral palsy.

Authors:  A-K Finbråten; U Syversen; J Skranes; G L Andersen; R D Stevenson; T Vik
Journal:  Osteoporos Int       Date:  2014-08-14       Impact factor: 4.507

4.  Bone mineral density and vitamin D status in children with epilepsy, cerebral palsy, and cerebral palsy with epilepsy.

Authors:  Ayse Tosun; Seda Erisen Karaca; Tolga Unuvar; Yakup Yurekli; Cigdem Yenisey; Imran Kurt Omurlu
Journal:  Childs Nerv Syst       Date:  2016-10-18       Impact factor: 1.475

5.  Adaptation of the lateral distal femur DXA scan technique to adults with disabilities.

Authors:  Richard C Henderson; Brent A Henderson; Heidi H Kecskemethy; Sebastian T Hidalgo; Beth Ann Nikolova; Kevin Sheridan; H Theodore Harcke; Deborah E Thorpe
Journal:  J Clin Densitom       Date:  2014-06-03       Impact factor: 2.617

6.  A pediatric animal model to evaluate the effects of disuse on musculoskeletal growth and development.

Authors:  Daniel L Miranda; Melissa Putman; Ruby Kandah; Maria Cubria; Sebastian Suarez; Ara Nazarian; Brian Snyder
Journal:  J Biomech       Date:  2016-08-24       Impact factor: 2.712

Review 7.  Fractures in children with cerebral palsy.

Authors:  M Zulf Mughal
Journal:  Curr Osteoporos Rep       Date:  2014-09       Impact factor: 5.096

Review 8.  Bisphosphonate treatment for children with disabling conditions.

Authors:  Alison M Boyce; Laura L Tosi; Scott M Paul
Journal:  PM R       Date:  2013-12-22       Impact factor: 2.298

9.  Aging and bone health in individuals with developmental disabilities.

Authors:  Joan Jasien; Caitlin M Daimon; Stuart Maudsley; Bruce K Shapiro; Bronwen Martin
Journal:  Int J Endocrinol       Date:  2012-07-22       Impact factor: 3.257

10.  Bisphosphonate use in children with cerebral palsy.

Authors:  Tim Hurley; Zunera Zareen; Philip Stewart; Ciara McDonnell; Denise McDonald; Eleanor Molloy
Journal:  Cochrane Database Syst Rev       Date:  2021-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.